Fox Chase Cancer Center News

WASHINGTON, DC (April 9, 2013)—A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, according to new findings presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Tuesday, April 9.

WASHINGTON, DC (April 9, 2013)—Researchers at Fox Chase Cancer Center have identified a host of small molecules critical to metabolism in cells of triple-negative breast cancer—one of the least understood groups of breast cancer. These molecules, called metabolites, include key players in energy regulation and lipid synthesis. They could help pave the way for helping researchers differentiate among different forms of the disease and ultimately point to new targets for treatment.

WASHINGTON, DC (April 8, 2013)—Once considered part of the “junk” of our genome, much of the DNA between protein-coding genes is now known to be transcribed. New findings by scientists at Fox Chase Cancer Center have identified several dozen transcripts known as lincRNAs, or long intergenic non-coding RNAs, that are dysregulated in breast cancer.

WASHINGTON, DC (April 7, 2013)—Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date of their diagnosis. Most colorectal cancers are adenocarcinomas—cancers that begin in cells that make and release mucus and other fluids. Adenocarcinomas begin as benign tumors called adenomas, which become malignant over time.

WASHINGTON, DC (April 7, 2013)—Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.

"People with issues in their immune system such as HIV will be at risk of acquiring HPV, as well – and the current vaccine may not fully protect them," says study author Elizabeth Blackman, MPH, research specialist at Fox Chase.

PHILADELPHIA (March 25, 2013)—The American Association for Cancer Research will inaugurate the first class of the Fellows of the AACR Academy at the AACR Annual Meeting 2013, held in Washington, D.C., April 6-10. Inductees include Beatrice Mintz, PhD, and Alfred G. Knudson Jr., MD, PhD.

PHILADELPHIA, PA (March 21, 2013)—Fox Chase Cancer Center will be hosting a  one-day, no-cost symposium for high school students to learn about potential careers in medicine, nursing, science, information technology, and business administration. The Health Careers Symposium will take place on Saturday, March 23, from 8:00 a.m. – 4:30 p.m. on Fox Chase Cancer Center’s main campus (333 Cottman Avenue, Philadelphia).

FORT WASHINGTON, PA (March 14, 2013)—The National Comprehensive Cancer Network® (NCCN®) has issued its first-ever NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Survivorship. NCCN Guidelines® Panel Chair Crystal S. Denlinger, MD, Attending Physician and Assistant Professor of Medical Oncology, Fox Chase Cancer Center, was among those who presented the new NCCN Guidelines at the NCCN 18th Annual Conference: Advancing the Standard of Cancer Care™.